Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 141 ~ 160 of 25713, Page 8 of 1287
141. New Approvals Allow Chronic Pain Sufferers to Try Abbott''s Non-Opioid Pain Therapy Before Getting Device Implant
Neurostimulation of the dorsal root ganglion (DRG) can provide pain relief for patients battling chronic pain when previous treatment options were unsuccessful / Abbott's new DRG Invisible Trial System brings an intuitive, wireless approach to the temporary evaluation giving patients the full benefits of DRG therapy prior to permanent implant
11/15/2018 Abbott
142. Suicide Increasing Among American Workers
Rates highest for males in construction and extraction; females in arts, design, entertainment, sports, and media
11/15/2018 Centers for Disease Control and Prevention
143. Statement from FDA Commissioner Scott Gottlieb, M.D., on proposed new steps to protect youth by preventing access to flavored tobacco products and banning menthol in cigarettes
As a physician who cared for hospitalized cancer patients, I saw first-hand the devastation that smoking-related diseases had wrought on the lives of patients and their families, and dedicated myself to helping ease this suffering
144. Results from 2018 National Youth Tobacco Survey show dramatic increase in e-cigarette use among youth over past year
Sharp rise in e-cigarette use results in uptick in overall tobacco product use; prompts new, forceful steps by FDA to firmly confront and reverse youth epidemic
145. Abbott and The Chertoff Group Explore Current State of Cybersecurity in the Connected Hospital
New White Paper Shares Research Findings on Perceptions and Awareness of Medical Device Cybersecurity, Need for Collaboration to Address Cybersecurity Challenges
11/15/2018 Abbott
146. Adolescent and Young Adult Cancer Survival Rates Increase When Re-evaluated
A new way of looking at the data of adolescents and young adults (AYAs) with cancer shows survival rates among this age group are much better than previously thought.
11/15/2018 American Cancer Society
147. AMA Statement on FDA Plan to Prevent Youth Access to Flavored Tobacco
The AMA applauds FDA’s announcement of its plan to make harmful tobacco products less accessible and less appealing to our nation’s youth.
11/15/2018 American Medical Association
148. FDA alerts doctors, patients about risk of complications when certain implanted pumps are used to deliver pain medications not approved for use with the devices
149. Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Compared to Chemotherapy in Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Express PD-L1 (CPS ≥10)
With Pivotal KEYNOTE-181 Trial Meeting Primary Endpoint of OS, KEYTRUDA Becomes the First Anti-PD-1 Therapy to Demonstrate a Survival Benefit for These Patients
11/14/2018 MERCK
150. AMA President Outlines Efforts to Attack Dysfunction in Health Care
11/14/2018 American Medical Association
151. Newest Prediabetes Awareness Campaign by Nation’s Medical Authorities Spreads the Word: 1 in 3 Americans Has Prediabetes, Learn Your Risk
On World Diabetes Day 2018, the American Medical Association (AMA), the Centers for Disease Control and Prevention (CDC) and the Ad Council continue the fight against type 2 diabetes
11/14/2018 Centers for Disease Control and Prevention
152. Prediabetes Campaign: 1 in 3 in U.S. Has Prediabetes, Learn Your Risk
On World Diabetes Day 2018, the AMA, the CDC and the Ad Council continue the fight against type 2 diabetes.
11/14/2018 American Medical Association
153. Abbott Recommends Rejection of Below-Market Mini-Tender Offer by Baker Mills LLC
ABBOTT PARK, Ill., Nov. 14, 2018 /PRNewswire/ --?Abbott (NYSE: ABT) received notice of an unsolicited mini-tender offer by Baker Mills LLC (Baker Mills) to purchase up to 60,000 Abbott common shares, representing approximately 0.003 percent of the company''''s outstanding shares. Baker Mills'''' offer price of $57.00 per share in cash is approximately 22 percent lower than the $72.79 closing price of Abbott common shares on Nov. 9, 2018, the last closing price prior to commencement of the offer.
11/14/2018 Abbott
154. Merck Begins Rolling Submission of Licensure Application for V920 (rVSV G-ZEBOV-GP) to U.S. Food and Drug Administration
V920 is the Company's Investigational Vaccine for Ebola Zaire
11/13/2018 MERCK
155. FDA warns StemGenex Biologic Laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk
The U.S. Food and Drug Administration has warned StemGenex Biologic Laboratories LLC (StemGenex) of San Diego, Calif; its owner/manager Rita F. Alexander and laboratory and medical director Jenny R. Galloway, M.D. about marketing a purported stem cell product without FDA approval ...
156. AMA Adopts New Policies at 2018 Interim Meeting
Affirming the Medical Spectrum of Gender / Protecting the Integrity of Public Health Data Collection / Opposing the Detention of Migrant Children / Increased Access to Identification Cards for the Homeless Population / Increasing Patient Access to Sexual Assault Medical Forensic Examinations and Post-Exposure Prophylaxis (PEP) for HIV in Emergency Departments
11/13/2018 American Medical Association
157. New AMA Policies Adopted on Final Day of 2018 Interim Meeting
Protecting and Improving Access to Zero-dollar Preventive Care / Continued 9-1-1 Modernization and Implementation of Text-to-9-1-1 Service / Expanding Broadband and Wireless Connectivity / Sexual Assault Education and Prevention in Public Schools
11/13/2018 American Medical Association
158. Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System
Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease
11/13/2018 Medtronic
159. Future Physicians Should Seek Training to Enhance Access to Rural Care
The AMA encourages medical students and residents to seek training opportunities in public and population health to increase access to care in rural areas.
11/13/2018 American Medical Association
160. AMA Policy Aimed at Preventing Medical Student and Physician Suicide
The AMA adopted policy during its Interim Meeting aimed at identifying patterns that could predict and ultimately prevent suicide among physicians-in-training.
11/13/2018 American Medical Association
1 2 3 4 5 6 7 8 9 10
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱